Therapeutic Eye Massager NURIEYE - 5800

Treatment of dry eye syndrome and relief of minor periocular muscular pain

Product Features

Pleasant air pressure massage

Thermal massage

Vibration massage of 15 sorts

Convenient LCD remote control in English and Korean

Mode, Time setting - Auto / Manual setting is possible

Both battery and AC adaptor use

How to use for skin wrinkles and whitening

Massage the skin with NURIEYE-5800 for 15 minutes, And after applying eye serum and eye cream, give a thermal massage with NURIEYE-5800 for 15 minutes additionally.

* The efficacy and effects of functional cosmetics are irrelevant to the efficacy and effects of medical devices.

It relaxes the stiff periocular muscles by vibration, air pressure and thermal massages, and it is good for dry eye, fatigue eyes, and periocular muscular ache.

Comparative, Open, Randomized and Multi-institution Clinical Test Research for the Evaluation of Safety and Efficacy of Medical Vibrator (NURIEYE-5800) to Patients with Dry Eye Syndrome.

Study on NURIEYE-5800 (Clinical Test Report)

Human eyes rapidly get worsened due to air pollution, surrounding environment and stress as the eyes blink once per 3 seconds and people look at things keeping the eyes open for 16~18 hours each day, sleeping for 8 hours a day, There are blood vessels, lachrymal glands and nervous tissues arround the eyes and the young ones' eyes get dry since the periocular blood vessels are blocked, blood does not circulate well and the lachrymal glands are blocked as the eyes are open for a long time, When the age is over 40, the eyes get dry and hard headache and bloodshot eyes as the eye nervous tissues get hardened, as aged people have presbyopia, the inlet canalis are blocked and tears flow out as tears do not circulate, The phenomenon is caused by hardening of periocular muscles, and it has been medically and scientifically proved that massage to the stiff periocular muscle and acupuncture point is good, The purpose of this clinical test is to evaluate the clinical efficacy and safety of using the medical vibrators for the patients with dry eye syndrome, and the superiority of the tested medical device for the control group 1 (artificial tear) and the non-inferiority of the tested medical device for the control group 2 (eye drops) have been proved by the evaluation of symptom improvement through OSDI 4 weeks after the treatment of the tested medical device for subjects.

As a result of the measurement of intraocular pressure, the difference of both right and left eyes of 4 weeks comparing the baseline has been statistically reduced at the significant level of 5%, (P-value=0.0311, 0.0335).

It is judged that the intraocular pressure has been caused due to the function to massage the periocular as the characteristic of the medical device for test group clinical test, is known that the increase of intraocular pressure is associated with various eye diseases such as glaucoma, and it is judged that the safety of the medical device gor the test group clinical test that brought the reduction is proved,
Thus it is judged that the safety of the medical device for the test group clinical test is not different comparing with the control group 1 (artificial tear) and the contro group 2 (eye drops), the result of this clinical test can provide patients with the opportunity of choice by using a medical device beside of artificial tear or eye drops for the treatment of dry eye syndrome, and it is greatly meaningful to get the clinical effect by the use for a month,

In addition, it is judged that the medical device for test group clinical test is effective for the treatment of dry eye syndrome and the periocular massage has various advantages comparing with the control group 1 (artificaal tear) and the control group 2(eye drops), and it has been proved that it gives larger effect for the treatment of dry eye syndrome when it is used together with artificial tear or eye drops, The medical device has obtained the approval of "Treatment of dry eye syndrome and relief of minor periocular muscular pain" from Korea Food & Drug Administration.